Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in Intravacc-led CDMO programs Intravacc has used its Vero cell line ...

Respiratory infections remain one of the major global public health threats. According to the World Health Organization, respiratory diseases—such as chronic obstructive pulmonary disease (COPD) and ...

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners developing next-generation ...

TG-MVATM uses a scalable cell line manufacturing process intended to strengthen and diversify global mpox and smallpox vaccine supplyTG-MVATM ...

The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 outbreak. By Stephanie Nolen Stephanie Nolen spoke with scientists, health ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

SK bioscience partners with US CDC to develop injectable rotavirus vaccine Deal aims to boost access and efficacy of ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...

Cancer immunotherapy approaches that induce or amplify endogenous antitumour T cell responses require the presentation of tumour-specific antigens by human leukocyte antigen (HLA) molecules on the ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.